Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Pharmacokinetics of JT408T (ambroxol hydrochloride) in Healthy Japanese Males
jRCT2051210024Phase 1Completed
- Sponsor
- JCR Pharmaceuticals
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ambroxol in Gaucher disease (GD) (2 arms), sponsored by JCR Pharmaceuticals. Primary endpoint: Safety and tolerability (adverse events). Started Jun 2021; status: completed.
02
Drugs
ambroxol
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on jRCT2051210024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051210024.